Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Vigneri

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Proteins|January 11, 2007
Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfoldedPietro Buffa, Livia Manzella, Maria Letizia Consoli, et al.
Future Oncology (London, England)|January 10, 2020
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcomaFederica Martorana, Paolo Vigneri, Livia Manzella, et al.
Oncotargets and Therapy|April 14, 2023
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so FarStefania Stella, Federica Martorana, Michele Massimino, et al.
Critical Reviews in Oncology/Hematology|February 6, 2023
The optimal timing between neoadjuvant therapy and surgery of breast cancer: A brief systematic review of the literatureRossi Lorenzo, Francesco Meani, Claudio Longhitano, et al.
Cancer Research|October 3, 2003
p73 tumor-suppressor activity is impaired in human thyroid cancerFrancesco Frasca, Veronica Vella, Alessandra Aloisi, et al.
Expert Review of Anticancer Therapy|February 9, 2016
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomesFabio Stagno, Stefania Stella, Antonio Spitaleri, et al.
Molecular Cancer|April 18, 2012
IRF5 promotes the proliferation of human thyroid cancer cellsMichele Massimino, Paolo Vigneri, Manuela Fallica, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Practical Approach to the Diagnosis of the Vulvo-Vaginal Stromal Tumors: An OverviewGiuseppe Angelico, Stefano Marletta, Giuseppe Broggi, et al.
Molecular Cancer Therapeutics|March 29, 2013
Suppression of survivin induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugsStefania Stella, Elena Tirrò, Enrico Conte, et al.
Genes|July 29, 2023
Single-Cell Analysis in the <i>Omics</i> Era: Technologies and Applications in CancerMichele Massimino, Federica Martorana, Stefania Stella, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Proteins|January 11, 2007
Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfoldedPietro Buffa, Livia Manzella, Maria Letizia Consoli, et al.
Future Oncology (London, England)|January 10, 2020
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcomaFederica Martorana, Paolo Vigneri, Livia Manzella, et al.
Oncotargets and Therapy|April 14, 2023
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so FarStefania Stella, Federica Martorana, Michele Massimino, et al.
Critical Reviews in Oncology/Hematology|February 6, 2023
The optimal timing between neoadjuvant therapy and surgery of breast cancer: A brief systematic review of the literatureRossi Lorenzo, Francesco Meani, Claudio Longhitano, et al.
Cancer Research|October 3, 2003
p73 tumor-suppressor activity is impaired in human thyroid cancerFrancesco Frasca, Veronica Vella, Alessandra Aloisi, et al.
Expert Review of Anticancer Therapy|February 9, 2016
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomesFabio Stagno, Stefania Stella, Antonio Spitaleri, et al.
Molecular Cancer|April 18, 2012
IRF5 promotes the proliferation of human thyroid cancer cellsMichele Massimino, Paolo Vigneri, Manuela Fallica, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Practical Approach to the Diagnosis of the Vulvo-Vaginal Stromal Tumors: An OverviewGiuseppe Angelico, Stefano Marletta, Giuseppe Broggi, et al.
Molecular Cancer Therapeutics|March 29, 2013
Suppression of survivin induced by a BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugsStefania Stella, Elena Tirrò, Enrico Conte, et al.
Genes|July 29, 2023
Single-Cell Analysis in the <i>Omics</i> Era: Technologies and Applications in CancerMichele Massimino, Federica Martorana, Stefania Stella, et al.
Pageof 15